Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial.
Alireza RamezaniHossein MolazemMorteza EntezariHomayoun NikkhahM D Saman RezanejadMehdi YaseriPublished in: Journal of ophthalmic & vision research (2024)
This crossover clinical trial demonstrated that in the course of DME treatment with IVB injections, topical ketorolac did not have any additive beneficial effect at least during a six-week period.